Search by Drug Name or NDC

    NDC 69848-0016-10 Sennosides 17.2 mg/17.21 Details

    Sennosides 17.2 mg/17.21

    Sennosides is a ORAL CAPSULE, LIQUID FILLED in the HUMAN OTC DRUG category. It is labeled and distributed by Granules USA Inc. The primary component is SENNOSIDES.

    Product Information

    NDC 69848-0016
    Product ID 69848-016_0d80da2f-713a-6768-e063-6394a90aed00
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Sennosides
    Proprietary Name Suffix n/a
    Non-Proprietary Name Sennosides
    Product Type HUMAN OTC DRUG
    Dosage Form CAPSULE, LIQUID FILLED
    Route ORAL
    Active Ingredient Strength 17.2
    Active Ingredient Units mg/17.21
    Substance Name SENNOSIDES
    Labeler Name Granules USA Inc
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH DRUG
    Application Number M007
    Listing Certified Through 2024-12-31

    Package

    NDC 69848-0016-10 (69848001610)

    NDC Package Code 69848-016-10
    Billing NDC 69848001610
    Package 100 CAPSULE, LIQUID FILLED in 1 BOTTLE (69848-016-10)
    Marketing Start Date 2020-05-29
    NDC Exclude Flag N
    Pricing Information N/A